TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Gilead Sciences Norway AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
16,506
|
10,040
|
10,045 |
Financial expenses |
1
|
9
|
19 |
Earnings before taxes |
622
|
346
|
333 |
Total assets |
11,616
|
9,693
|
9,616 |
Current assets |
11,551
|
9,693
|
9,616 |
Current liabilities |
4,523
|
2,663
|
2,477 |
Equity capital |
7,093
|
7,030
|
7,139 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) | 6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
61.1%
|
72.5%
|
74.2% |
Turnover per employee | 1,674 | ||
Profit as a percentage of turnover |
3.8%
|
3.4%
|
3.3% |
Return on assets (ROA) |
5.4%
|
3.7%
![]() |
3.7% |
Current ratio |
255.4%
|
364.0%
|
388.2% |
Return on equity (ROE) |
8.8%
|
4.9%
|
4.7% |
Change turnover |
7,104
|
523
|
-4,674 |
Change turnover % |
76%
|
5%
|
-32% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.